In Vivo Biodistribution and Lifetime Analysis of Cy5.5-Conjugated Rituximab in Mice Bearing Lymphoid Tumor Xenograft Using Time-Domain Near-Infrared Optical Imaging
Rituximab is a chimeric monoclonal antibody directed against human CD20 antigen, which is expressed on B-cell lymphocytes and on the majority of B-cell lymphoid malignancies. Herein we report the conjugate of rituximab with the near-infrared (NIR) fluorophore Cy5.5 (RI-Cy5.5) as a tool for in vitro,...
Saved in:
| Main Authors: | Stefania Biffi, Chiara Garrovo, Paolo Macor, Claudio Tripodo, Sonia Zorzet, Erika Secco, Francesco Tedesco, Vito Lorusso |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2008-11-01
|
| Series: | Molecular Imaging |
| Online Access: | https://doi.org/10.2310/7290.2008.00028 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fluorescence imaging of MALAT1 expression using a Cy5.5-labeled antisense oligonucleotide in lung cancer and epidermal carcinoma cells
by: Zhenfeng Liu, et al.
Published: (2025-07-01) -
89Zr-pembrolizumab biodistribution is influenced by PD-1-mediated uptake in lymphoid organs
by: Annelies Jorritsma-Smit, et al.
Published: (2020-10-01) -
Semiautomatic Landmark-Based Two-Dimensional—Three-Dimensional Image Fusion in Living Mice: Correlation of Near-Infrared Fluorescence Imaging of Cy5.5-Labeled Antibodies with Flat-Panel Volume Computed Tomography
by: Christian Dullin, et al.
Published: (2009-01-01) -
Impella 5.5 use in women: A multicenter study
by: Michaela Asher, MPhil, et al.
Published: (2025-08-01) -
Early biodistribution and persistence of a protective live attenuated SIV vaccine elicits localised innate responses in multiple lymphoid tissues.
by: Deborah Ferguson, et al.
Published: (2014-01-01)